Devin Rosenthal

Dr. Rosenthal has broad operational and strategic experience across a range of therapeutic areas, stages of development, and company types within the biopharmaceutical industry.
As a member of the NovaQuest Capital investment team, he is responsible for investment due diligence, deal sourcing, and transaction structuring.
Prior to joining NovaQuest, Dr. Rosenthal was a Senior Consultant at Triangle Insights Group, a boutique life sciences strategy consulting firm, where he focused on corporate strategy, due diligence, mergers and acquisitions, and commercial forecasting.
His earlier experience includes work in product development and regulatory affairs at Rho, a mid-size contract research organization; companion diagnostics at Novartis Oncology; and clinical development at Boston Biomedical Inc.